Next Article in Journal
A Study of Older Adults’ Perception of High-Density Housing Neighbourhoods in Singapore: Multi-Sensory Perspective
Next Article in Special Issue
Associations between Per- and Polyfluoroalkyl Substances (PFAS) and Cardiometabolic Biomarkers in Adults of Czechia: The Kardiovize Study
Previous Article in Journal
What Does the Future Hold? Health-Related Quality of Life 3–12 Years Following a Youth Sport-Related Knee Injury
Previous Article in Special Issue
Health Impact Assessment of Artisanal and Small-Scale Gold Mining Area in Myanmar, Mandalay Region: Preliminary Research
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 18
Issue 13
10.3390/ijerph18136879
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Combined Effect of Lead Exposure and Allostatic Load on Cardiovascular Disease Mortality—A Preliminary Study

by
Emmanuel Obeng-Gyasi
1,2,*,
Alesia C. Ferguson
1,
Katherine A. Stamatakis
3 and
Michael A. Province
4
1
Department of Built Environment, North Carolina A&T State University, Greensboro, NC 27411, USA
2
Environmental Health and Disease Laboratory, North Carolina A&T State University, Greensboro, NC 27411, USA
3
Department of Epidemiology and Biostatistics, College for Public Health & Social Justice, Saint Louis University, St. Louis, MO 63103, USA
4
Department of Genetics, Washington University School of Medicine St. Louis, St. Louis, MO 63130, USA
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2021, 18(13), 6879; https://doi.org/10.3390/ijerph18136879
Submission received: 4 June 2021 / Revised: 24 June 2021 / Accepted: 25 June 2021 / Published: 26 June 2021
(This article belongs to the Special Issue Multiple Environmental Exposures and Cardiorespiratory Diseases)
Versions Notes

Abstract

:
This study explores the combined effect of lead (Pb) exposure and an index of chronic physiological stress on cardiovascular disease mortality using data from the National Health and Nutrition Examination Survey (NHANES) 1999–2008 linked to 1999–2014 National Death Index data. Chronic physiological stress was measured using the allostatic load (AL) index, which was formed by analyzing markers from the cardiovascular, inflammatory, and metabolic systems, with Pb levels, assessed using blood lead levels (BLL). The dataset was analyzed with statistical techniques to explore (a) the relationship between Pb exposure and AL, and (b) the combined role of Pb and AL on cardiovascular disease mortality. Results indicated that AL was more elevated in those with BLLs above the 50th percentile in the US population and that those with elevated AL were more likely to have high BLL. Finally, the interaction of AL and BLL significantly increased the likelihood of cardiovascular disease mortality. These findings highlight the need for considering the totality of exposures experienced by populations to build holistic programs to prevent Pb exposure and reduce stressors to promote optimal health outcomes and reduce cardiovascular mortality risk.

1. Introduction

In the US population, cardiovascular diseases are the leading cause of mortality [1]. Numerous epidemiological studies have linked lead (Pb) exposure with adverse cardiovascular disease outcomes [2,3,4,5]. According to the Centers for Disease Control and Prevention (CDC), any exposure to Pb can induce disease and dysfunction in children [6].
Lead (Pb) is an environmentally and biologically persistent source of adverse outcomes affecting nearly all the organ systems in the human body [7,8,9,10,11,12]. Sources of Pb exposure in the United States include Pb-based paint, contaminated soil, drinking water, workplace sources (e.g., battery manufacturing), and Pb-contaminated imported goods [13]. Adults are primarily exposed to Pb in the workplace [14] with 5 μg/dL used as the case classification by the Adult Blood Lead Epidemiology and Surveillance (ABLES) to indicate an elevated BLL for surveillance purposes [15]. However, the US Centers for Disease Control and Prevention (CDC) have concluded that no Pb exposure level is safe for adults as adverse health outcomes have been documented at all exposure concentrations [6,16]. Race is a critical factor in Pb exposure risk in the United States, with environmental inequities leaving Black populations disproportionately exposed. Owing in part to environmental racism, social and environmental conditions such as residential location, education, and employment have historically led to greater exposure in minority populations to environmental hazards such as Pb, with prevention and remediation of exposure sources being slow for affected groups [17,18].
Cardiovascular disease risk factors, such as hypertension, diabetes mellitus, and cardiovascular diseases, such as heart failure and ischemic heart disease, play a significant role in cardiovascular disease mortality [19]. Environmental contaminants such as Pb may also play a role in cardiovascular disease mortality. The role of Pb in cardiovascular disease mortality was explored in a 2018 study by Lanphear and colleagues, in which they estimated that 256,000 premature deaths from cardiovascular diseases, including 185,000 deaths from ischemic heart disease, may be linked to Pb exposure adults [20].
Allostatic Load (AL), a measure of chronic stress, represents the hypothalamic–pituitary–adrenal (HPA) axis in an over-activated state and involves dysregulation of multiple physiological systems [21]. Dysregulation of the HPA axis, critical for regulating neuroendocrine system responses to stressful stimuli, has been associated with cardiovascular dysfunction [22]. AL offers vital insight into the effects of chronic stress on health outcomes [23,24,25,26].
Epidemiological studies have demonstrated that chronic stress predicts the occurrence of coronary heart disease (CHD), with even short-term emotional stress triggering cardiac events [27,28]. Studies have also found that stress plays a role in cardiovascular mortality [29,30].
Pb may also increase the stress response. In a study of Pb-exposed workers, Chang and colleagues found high plasma norepinephrine but normal plasma dopamine and epinephrine levels, pointing to heightened sympathetic nervous system activity [31]. Gump and colleagues found that after an acute stressor, increasing prenatal and postnatal blood Pb levels were independently associated with significantly heightened salivary cortisol responses [32], with Pb’s effect on salivary cortisol confirmed by others [33]. Regarding chronic stress, Zota and colleagues found that AL may amplify the adverse effects of Pb on blood pressure [33], with other studies confirming Pb exposure at lower levels contributing to AL and in adults [34].
People’s daily activities, including their diet, neighborhood, environmental exposures, social interactions, and lifestyle behaviors such as alcohol and smoking, affect health outcomes. The exposome, a concept that seeks to assess the cumulative measure of environmental impacts and related biological responses throughout the life-course, including exposures from diet, behavior, the environment, and endogenous processes, better reflects populations’ exposure risk. The combined effect of Pb and life stressors on cardiovascular disease mortality is thus critical to study since both may have a cumulative impact on the cardiovascular system.
Prior studies by the lead author have demonstrated potential associations between AL and cardiovascular dysfunction among those exposed to differing concentrations of Pb, but more information is needed to understand how the combination of Pb and AL contributes to cardiovascular disease mortality [35].
This study had two objectives:
1: Determine the association between Pb and AL among adults.
2: Determine the association between the combined effect of AL and Pb on cardiovascular disease mortality among adults.

2. Materials and Methods

This study examined the association between BLL and AL, and the combined effect of BLL and AL on cardiovascular disease mortality in adults using data from the National Health and Nutrition Examination Survey linked to the National Death Index. Biological and clinical markers from multiple physiological systems such as the cardiovascular, inflammatory, and metabolic systems were used to develop the AL index. AL, an established index of chronic stress [21,36,37,38,39,40,41], is a suitable means to explore the role of Pb and chronic stress in adults, as it represents the cumulative wear-and-tear on the body.

2.1. Measures

Allostatic Load Index:
Informed by prior studies [35,42,43], a cumulative index of physiologic dysfunction of the cardiovascular (SBP, DBP, triglycerides, HDL cholesterol, total cholesterol), inflammatory (CRP), and metabolic systems (BMI, hemoglobin A1C, albumin, creatinine clearance) was developed. AL markers were divided into quartiles based on their distribution within the database. High-risk for each biomarker was considered to be the top 25% in the distribution for all markers apart from albumin, creatinine clearance, and HDL cholesterol, for which the bottom 25% of the distribution was considered to have the highest [44,45,46,47,48,49,50]. Each individual in the study was assigned a value of 1 if they are in the high-risk category or a 0 if in the low-risk category for all markers to calculate a total AL value out of 10. Clinical and laboratory collection and analysis of markers and variables of interest have been described elsewhere [35,43].

2.2. Data and Study Design

The relationships in this study were explored using NHANES 1999 to 2008. Mortality was determined from linked 1999–2014 National Death Index data. NHANES data is a stratified, multistage probability sample of civilian non-institutionalized individuals in all of the 50 US states, including the District of Columbia. Technical details of the survey, including sampling design, data collection protocols, and data availability, are freely available on their website. Data collection for NHANES makers of interest have been described elsewhere [35]. This study used de-identified secondary data; hence, the study did not require IRB approval.

2.3. Data Analysis

Variables of interest were explored in adults aged 20 or older in those with BLL above the 50th percentile in the US population as compared to those with BLL below the 50th percentile. This study included an overall eligible sample of 28,852 adults with 52.05% being female.
Linear regression and logistic regression were used to explore the association between AL and BLL in adults by dichotomizing low AL ( <3 or <4 ) vs. high AL ( ≥3 or ≥4) for logistic regression, as high AL subjects using this definition have been consistently shown in the literature to be at high risk of adverse health outcomes from chronic stress [51,52,53].
Synergistic effects of co-exposures to high values of both blood Pb and AL on cardiovascular mortality were determined by estimating odds ratios concerning exposures to low values of both blood Pb and AL.
Cox proportional hazards regression was used to model the risk of death with less-stressed (AL <3) and low Pb exposure (BLL < 50th percentile in population) participants as the reference groups. Additional covariates used were gender, BMI, alcohol consumption, smoking, and country of birth, as these factors were different across Pb exposure levels and the literature has demonstrated they may confound variables of interest.
Stata SE/16.0 (StataCorp, College Station, TX, USA) was used for the analysis as it factored in the complex design to ensure the analysis reflected the proper weights.

3. Results

3.1. Summary Statistics of Variables of Interest

Variables of interest we explored above and below the median BLL (1.55 μg/dL) were among adults aged 20–85 years old (Table 1). The mean AL above the 50th percentile BLL was significantly more elevated than below the 50th percentile, indicating the role Pb may play in elevating AL.
The proportion of non-Hispanic Blacks and Mexican Americans increased above the 50th percentile in BLL as compared to other ethnicities while the proportion of non-Hispanic Whites significantly (p < 0.05) decreased.

3.2. Association between AL and BLL

Linear and logistic regression models indicated that blood Pb was significantly associated with AL (Table 2). For logistic regression models, the threshold of an AL of 3 and 4 were both significantly associated with BLL even after adjusting for critical covariates.

3.3. Association between Pb Exposure and Cardiovascular Disease Mortality

We explored the association of cardiovascular disease mortality risk with BLL, AL, and the interaction of AL and BLL (AL X BLL) using cox proportional hazard ratios. The results indicated that cardiovascular mortality was 2.35 times higher in those with BLL above the 50th percentile in the US population as compared to below. The results also found that the combined effect of Pb and AL was 1.82 times higher in those with BLL above the 50th percentile and AL above 3 as compared to below. The results are found in Table 3 below.

4. Discussion

Understanding the totality of exposures that contribute to cardiovascular disease mortality is critical to mitigating the leading cause of death in the United States and world. These high rates can be lowered only if the causes are understood. This study adds to the literature on the effects of social and environmental exposures on cardiovascular disease mortality.
With adjustment for demographic factors and some important potential confounders, we observed a positive association between blood Pb and CVD mortality and the interaction of blood Pb and chronic physiological stress with cardiovascular disease mortality.
Race/Ethnicity was a critical factor in exposure. Even though non-Hispanic Whites are the largest segment of the US population in this study, and represented a large proportion of those with BLL above the 50th percentile, they were proportinally less exposed to Pb. Specifically, there was a substantial increase in the proprortion of non-Hispanic Blacks and Mexican Americans that were above the 50th percentile in BLL compared to below it, compared to other ethnicities suggesting that these ethnicities are more likely to be exposed to Pb as compared to their proportion in the population. This matches the work of others, which found that Pb concentrations were more elevated in non-Hispanic Blacks and Mexican-Americans than Whites [54].
The results finding an association of BLL with AL suggest that although BLLs of adults have continued to decline, the health impact of Pb and physiological stress are intricately linked. This may either mean that environments which have Pb tend to be filled with more stressors or it may indicate that those who are chronically stressed are more likely to work, live in homes, or consume Pb-contaminated items. In addition, because Pb exposure and stressors tend to occur concurrently with low socioeconomic status, these findings will likely have a more significant impact among these populations [55]. These results match the work of Lindgren and colleagues who found in a study of occupationally-exposed patients that cumulative Pb exposure was associated with general distress [56].
Our findings suggest that BLL may be more critical than AL in bringing forth cardiovascular disease mortality. The reason for this is difficult to disentangle in a study of this sort and would need lab-based methods to assess the mechanistic differences between both exposures. We hypothesize that varying degrees of inflammation and oxidative stress produced by both processes are likely critical in any differences that may be produced.
The exposure to environmental contaminants is rarely isolated. Most human beings are exposed to a complex mixture of many environmental [57,58] and social exposures [59,60], and the physiological manifestation of them determines the biological response both in the short and long term. The exposome embodies this concept and reflects the reality of how exposure occurs [61]. The co-occurrence of elevated Pb burden with higher levels of chronic stress increases the possibility of interactions of these risk factors. Further support for such a possibility derives from the fact that both Pb exposure and stress stimuli (through the hypothalamic-pituitary-adrenal [HPA] axis) act on dopamine/glutamate mesocorticolimbic systems of the brain [62,63].
AL and subsequent biological dysregulation bring forth cardiovascular disease [35,64,65]. When combined with Pb, the outcome can result in cardiovascular disease mortality in adult populations.
The results of this work suggest that public health agencies must target their messaging about behavioral interventions such as diet, exercise, and other resilient behaviors along with environmental messages about Pb exposure risk in order to holistically alleviate cardiovascular disease risk. In addition, prevention of Pb exposure risk from water [66], soil [67,68], and the air [69] is critical to mitigating risk. This will require governments to monitor water infrastructure and remediate areas impacted by legacy Pb.
Finally, more must be done to educate children in school environments about the risk of Pb exposure by giving the teacher the requisite knowledge and strategies [70] about the dangers of Pb exposure to provide students with the agency to mitigate Pb exposure risk at all stages of their lives.
Limitations of this study include blood Pb levels being used for the analysis. BLL represents acute exposure to Pb as the half-life for Pb in the blood is roughly 28 days. Bone Pb levels or Zinc protoporphyrin (ZPP) analysis would have given a better indication of more long-term exposure. Measuring lead in plasma may also have improved the study, as plasma lead levels may better reflect Pb that is more freely available for exchange with target tissues than Pb levels in whole blood [71]. Also, AL may not fully capture the experience and full impact of chronic stress related to health; however, it offers critical insight and is an accepted method to use with NHANES data [23,24,25,26].
Future work should explore these findings in a longitudinal study among various age groups. Indeed, as individuals age, their Pb exposure levels increase [72] due to its biological persistence, while stress levels have been found to decrease [73] with age in some studies. Future work should seek to understand the exact point in the life course where the Pb–stress interaction produces the most risk for cardiovascular disease mortality.

5. Conclusions

In summary, US Adults exposed to Pb are more likely to have elevated chronic stress levels. Finally, the combined effect of Pb and chronic physiological stress has a significant influence on cardiovascular disease mortality.

Author Contributions

Conceptualization, E.O.-G.; methodology, E.O.-G.; formal analysis, E.O.-G.; investigation, E.O.-G.; resources, E.O.-G.; data curation, E.O.-G.; writing—original draft preparation, E.O.-G.; writing—review and editing, E.O.-G., A.C.F., K.A.S., M.A.P.; supervision, E.O.-G.; project administration, E.O.-G.; funding acquisition, E.O.-G. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded in part by NHLBI grant R25 HL105400.

Institutional Review Board Statement

This study did not require IRB approval because de-identified secondary data were used. In the collection of the data by the Centers for Disease Control and Prevention, the study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of the Centers for Disease Control and Prevention ( Protocol #98-12, Protocol #2005-06, and Continuation of Protocol #2005-06).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The NHANES dataset is publicly available online, accessible at cdc.gov/nchs/nhanes/index.htm (Accessed on 18 June 2020).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Roth, G.A.; Johnson, C.O.; Abate, K.H.; Abd-Allah, F.; Ahmed, M.; Alam, K.; Alam, T.; Alvis-Guzman, N.; Ansari, H.; Ärnlöv, J. The burden of cardiovascular diseases among US states, 1990–2016. JAMA Cardiol. 2018, 3, 375–389. [Google Scholar]
  2. Lustberg, M.; Silbergeld, E. Blood lead levels and mortality. Arch. Intern. Med. 2002, 162, 2443–2449. [Google Scholar] [CrossRef] [Green Version]
  3. Hu, H.; Aro, A.; Payton, M.; Korrick, S.; Sparrow, D.; Weiss, S.T.; Rotnitzky, A. The relationship of bone and blood lead to hypertension: The Normative Aging Study. JAMA 1996, 275, 1171–1176. [Google Scholar] [CrossRef] [PubMed]
  4. Nash, D.; Magder, L.; Lustberg, M.; Sherwin, R.W.; Rubin, R.J.; Kaufmann, R.B.; Silbergeld, E.K. Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA 2003, 289, 1523–1532. [Google Scholar] [CrossRef] [Green Version]
  5. Reuben, A.; Caspi, A.; Belsky, D.W.; Broadbent, J.; Harrington, H.; Sugden, K.; Houts, R.M.; Ramrakha, S.; Poulton, R.; Moffitt, T.E. Association of childhood blood lead levels with cognitive function and socioeconomic status at age 38 years and with IQ change and socioeconomic mobility between childhood and adulthood. JAMA 2017, 317, 1244–1251. [Google Scholar] [CrossRef] [PubMed]
  6. Lead Toxicity-What Is the Biological Fate of Lead in the Body? Available online: https://www.atsdr.cdc.gov/csem/csem.asp?csem=34&po=9 (accessed on 1 July 2020).
  7. Obeng-Gyasi, E.; Armijos, R.X.; Weigel, M.M.; Filippelli, G.M.; Sayegh, M.A. Cardiovascular-related outcomes in US adults exposed to lead. Int. J. Environ. Res. Public Health 2018, 15, 759. [Google Scholar] [CrossRef] [Green Version]
  8. Obeng-Gyasi, E.; Armijos, R.X.; Weigel, M.M.; Filippelli, G.; Sayegh, M.A. Hepatobiliary-related outcomes in US adults exposed to lead. Environments 2018, 5, 46. [Google Scholar] [CrossRef] [Green Version]
  9. Sanders, T.; Liu, Y.; Buchner, V.; Tchounwou, P.B. Neurotoxic effects and biomarkers of lead exposure: A review. Rev. Environ. Health 2009, 24, 15. [Google Scholar] [CrossRef]
  10. Telišman, S.; Čolak, B.; Pizent, A.; Jurasović, J.; Cvitković, P. Reproductive toxicity of low-level lead exposure in men. Environ. Res. 2007, 105, 256–266. [Google Scholar] [CrossRef]
  11. Dundar, B.; Öktem, F.; Arslan, M.K.; Delibas, N.; Baykal, B.; Arslan, Ç.; Gultepe, M.; Ilhan, I.E. The effect of long-term low-dose lead exposure on thyroid function in adolescents. Environ. Res. 2006, 101, 140–145. [Google Scholar] [CrossRef] [PubMed]
  12. Obeng-Gyasi, E.; Roostaei, J.; Gibson, J.M. Lead Distribution in Urban Soil in a Medium-Sized City: Household-Scale Analysis. Environ. Sci. Technol. 2021, 55, 3696–3705. [Google Scholar] [CrossRef]
  13. Obeng-Gyasi, E. Sources of lead exposure in various countries. Rev. Environ. Health 2019, 34, 25–34. [Google Scholar] [CrossRef]
  14. Schwartz, B.S.; Hu, H. Adult lead exposure: Time for change. Environ. Health Perspect. 2007, 115, 451–454. [Google Scholar] [CrossRef] [Green Version]
  15. Fadeyi, M.O.; Alkhaja, K.; Sulayem, M.B.; Abu-Hijleh, B. Evaluation of indoor environmental quality conditions in elementary schools׳ classrooms in the United Arab Emirates. Front. Archit. Res. 2014, 3, 166–177. [Google Scholar] [CrossRef] [Green Version]
  16. Gavaghan, H. Lead, unsafe at any level. Bull. World Health Organ. 2002, 80, 82. [Google Scholar]
  17. Kraft, M.E.; Scheberle, D. Environmental justice and the allocation of risk: The case of lead and public health. Policy Stud. J. 1995, 23, 113–122. [Google Scholar] [CrossRef]
  18. Whitehead, L.S.; Buchanan, S.D. Childhood lead poisoning: A perpetual environmental justice issue? J. Public Health Manag. Pract. 2019, 25, S115–S120. [Google Scholar] [CrossRef] [PubMed]
  19. Redon, J.; Tellez-Plaza, M.; Orozco-Beltran, D.; Gil-Guillen, V.; Pita Fernandez, S.; Navarro-Pérez, J.; Pallares, V.; Valls, F.; Fernandez, A.; Perez-Navarro, A.M. Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: The ESCARVAL-risk study. J. Hypertens. 2016, 34, 1075–1083. [Google Scholar] [CrossRef]
  20. Lanphear, B.P.; Rauch, S.; Auinger, P.; Allen, R.W.; Hornung, R.W. Low-level lead exposure and mortality in US adults: A population-based cohort study. Lancet Public Health 2018, 3, e177–e184. [Google Scholar] [CrossRef]
  21. Juster, R.-P.; McEwen, B.S.; Lupien, S.J. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci. Biobehav. Rev. 2010, 35, 2–16. [Google Scholar] [CrossRef] [PubMed]
  22. Rosmond, R.; Björntorp, P. The hypothalamic–pituitary–adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J. Intern. Med. 2000, 247, 188–197. [Google Scholar] [CrossRef]
  23. Rodriquez, E.J.; Livaudais-Toman, J.; Gregorich, S.E.; Jackson, J.S.; Nápoles, A.M.; Pérez-Stable, E.J. Relationships between allostatic load, unhealthy behaviors, and depressive disorder in US adults, 2005–2012 NHANES. Prev. Med. 2018, 110, 9–15. [Google Scholar] [CrossRef] [PubMed]
  24. Ahrens, K.A.; Rossen, L.M.; Simon, A.E. Relationship Between Mean Leucocyte Telomere Length and Measures of Allostatic Load in US Reproductive-Aged Women, NHANES 1999–2002. Paediatr. Perinat. Epidemiol. 2016, 30, 325–335. [Google Scholar] [CrossRef] [PubMed]
  25. Borrell, L.N.; Rodríguez-Álvarez, E.; Dallo, F.J. Racial/ethnic inequities in the associations of allostatic load with all-cause and cardiovascular-specific mortality risk in US adults. PLoS ONE 2020, 15, e0228336. [Google Scholar] [CrossRef] [PubMed]
  26. Ghimire, S.; Hill, C.V.; Sy, F.S.; Rodriguez, R. Decline in telomere length by age and effect modification by gender, allostatic load and comorbidities in National Health and Nutrition Examination Survey (1999–2002). PLoS ONE 2019, 14, e0221690. [Google Scholar] [CrossRef] [Green Version]
  27. Matthews, K.A.; Gump, B.B.; Owens, J.F. Chronic stress influences cardiovascular and neuroendocrine responses during acute stress and recovery, especially in men. Health Psychol. 2001, 20, 403. [Google Scholar] [CrossRef]
  28. Öhlin, B.; Nilsson, P.; Nilsson, J.-Å.; Berglund, G. Chronic psychosocial stress predicts long-term cardiovascular morbidity and mortality in middle-aged men. Eur. Heart J. 2004, 25, 867–873. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Kivimäki, M.; Leino-Arjas, P.; Luukkonen, R.; Riihimäi, H.; Vahtera, J.; Kirjonen, J. Work stress and risk of cardiovascular mortality: Prospective cohort study of industrial employees. BMJ 2002, 325, 857. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Bruner, E.; Kivimäki, M.; Siegrist, J.; Theorell, T.; Luukkonen, R.; Riihimäki, H.; Vahtera, J.; Kirjonen, J.; Leino-Arjas, P. Is the effect of work stress on cardiovascular mortality confounded by socioeconomic factors in the Valmet study? J. Epidemiol. Community Health 2004, 58, 1019–1020. [Google Scholar] [CrossRef]
  31. Chang, H.-R.; Chen, S.-S.; Chen, T.-J.; Ho, C.-K.; Chiang, H.-C.; Yu, H.-S. Lymphocyte β2-adrenergic receptors and plasma catecholamine levels in lead-exposed workers. Toxicol. Appl. Pharmacol. 1996, 139, 1–5. [Google Scholar] [CrossRef]
  32. Gump, B.B.; Stewart, P.; Reihman, J.; Lonky, E.; Darvill, T.; Parsons, P.J.; Granger, D.A. Low-level prenatal and postnatal blood lead exposure and adrenocortical responses to acute stress in children. Environ. Health Perspect. 2008, 116, 249–255. [Google Scholar] [CrossRef]
  33. Zota, A.R.; Shenassa, E.D.; Morello-Frosch, R. Allostatic load amplifies the effect of blood lead levels on elevated blood pressure among middle-aged US adults: A cross-sectional study. Environ. Health 2013, 12, 64. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Souza-Talarico, J.N.; Suchecki, D.; Juster, R.-P.; Plusquellec, P.; Junior, F.B.; Bunscheit, V.; Marcourakis, T.; de Matos, T.M.; Lupien, S.J. Lead exposure is related to hypercortisolemic profiles and allostatic load in Brazilian older adults. Environ. Res. 2017, 154, 261–268. [Google Scholar] [CrossRef]
  35. Obeng-Gyasi, E.; Obeng-Gyasi, B. Chronic Stress and Cardiovascular Disease among Individuals Exposed to Lead: A Pilot Study. Diseases 2020, 8, 7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. McEwen, B.S. Plasticity of the hippocampus: Adaptation to chronic stress and allostatic load. Ann. N. Y. Acad. Sci. 2001, 933, 265–277. [Google Scholar] [CrossRef]
  37. Johnston-Brooks, C.H.; Lewis, M.A.; Evans, G.W.; Whalen, C.K. Chronic stress and illness in children: The role of allostatic load. Psychosom. Med. 1998, 60, 597–603. [Google Scholar] [CrossRef]
  38. McEwen, B.S. Protection and damage from acute and chronic stress: Allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann. N. Y. Acad. Sci. 2004, 1032, 1–7. [Google Scholar] [CrossRef]
  39. Evans, G.W.; Schamberg, M.A. Childhood poverty, chronic stress, and adult working memory. Proc. Natl. Acad. Sci. USA 2009, 106, 6545–6549. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Clark, M.S.; Bond, M.J.; Hecker, J.R. Environmental stress, psychological stress and allostatic load. Psychol. Health Med. 2007, 12, 18–30. [Google Scholar] [CrossRef]
  41. Russell, E.; Koren, G.; Rieder, M.; Van Uum, S. Hair cortisol as a biological marker of chronic stress: Current status, future directions and unanswered questions. Psychoneuroendocrinology 2012, 37, 589–601. [Google Scholar] [CrossRef] [PubMed]
  42. Sabbah, W.; Watt, R.; Sheiham, A.; Tsakos, G. Effects of allostatic load on the social gradient in ischaemic heart disease and periodontal disease: Evidence from the Third National Health and Nutrition Examination Survey. J. Epidemiol. Community Health 2008, 62, 415–420. [Google Scholar] [CrossRef] [PubMed]
  43. Obeng-Gyasi, E. Cumulative Effects of Low-Level Lead Exposure and Chronic Physiological Stress on Hepatic Dysfunction—A Preliminary Study. Med. Sci. 2020, 8, 30. [Google Scholar] [CrossRef]
  44. Goldbourt, U.; Yaari, S.; Medalie, J.H. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: A 21-year follow-up of 8000 men. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 107–113. [Google Scholar] [CrossRef] [Green Version]
  45. Mahon, N.G.; Blackstone, E.H.; Francis, G.S.; Starling, R.C.; Young, J.B.; Lauer, M.S. The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J. Am. Coll. Cardiol. 2002, 40, 1106–1113. [Google Scholar] [CrossRef] [Green Version]
  46. Horwich, T.B.; Kalantar-Zadeh, K.; MacLellan, R.W.; Fonarow, G.C. Albumin levels predict survival in patients with systolic heart failure. Am. Heart J. 2008, 155, 883–889. [Google Scholar] [CrossRef] [Green Version]
  47. Ackermann, R.T.; Cheng, Y.J.; Williamson, D.F.; Gregg, E.W. Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c: National Health and Nutrition Examination Survey 2005–2006. Am. J. Prev. Med. 2011, 40, 11–17. [Google Scholar] [CrossRef]
  48. Navas-Acien, A.; Guallar, E.; Silbergeld, E.K.; Rothenberg, S.J. Lead exposure and cardiovascular disease: A systematic review. Environ. Health Perspect. 2007, 115, 472–482. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Isomaa, B.; Almgren, P.; Tuomi, T.; Forsén, B.; Lahti, K.; Nissen, M.; Taskinen, M.-R.; Groop, L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24, 683–689. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Weverling-Rijnsburger, A.W.; Blauw, G.J.; Lagaay, A.M.; Knock, D.L.; Meinders, A.E.; Westendorp, R.G. Total cholesterol and risk of mortality in the oldest old. Lancet 1997, 350, 1119–1123. [Google Scholar] [CrossRef]
  51. Geronimus, A.T.; Hicken, M.; Keene, D.; Bound, J. “Weathering” and age patterns of allostatic load scores among blacks and whites in the United States. Am. J. Public Health 2006, 96, 826–833. [Google Scholar] [CrossRef]
  52. Crimmins, E.M.; Johnston, M.; Hayward, M.; Seeman, T. Age differences in allostatic load: An index of physiological dysregulation. Exp. Gerontol. 2003, 38, 731–734. [Google Scholar] [CrossRef]
  53. Kaestner, R.; Pearson, J.A.; Keene, D.; Geronimus, A.T. Stress, allostatic load, and health of Mexican immigrants. Soc. Sci. Q. 2009, 90, 1089–1111. [Google Scholar] [CrossRef] [PubMed]
  54. Theppeang, K.; Glass, T.A.; Bandeen-Roche, K.; Todd, A.C.; Rohde, C.A.; Schwartz, B.S. Gender and race/ethnicity differences in lead dose biomarkers. Am. J. Public Health 2008, 98, 1248–1255. [Google Scholar] [CrossRef]
  55. Dohrenwend, B.S. Social status and stressful life events. J. Personal. Soc. Psychol. 1973, 28, 225. [Google Scholar] [CrossRef]
  56. Lindgren, K.N.; Masten, V.L.; Tiburzi, M.J.; Ford, D.P.; Bleecker, M.L. The factor structure of the Profile of Mood States (POMS) and its relationship to occupational lead exposure. J. Occup. Environ. Med. 1999, 41, 3–10. [Google Scholar] [CrossRef]
  57. Babekir, A.; Mostafa, S.; Obeng-Gyasi, E. The Association of Toxoplasma gondii IgG and Cardiovascular Biomarkers. Int. J. Environ. Res. Public Health 2021, 18, 4908. [Google Scholar] [CrossRef]
  58. Obeng-Gyasi, E. Chronic cadmium exposure and cardiovascular disease in adults. J. Environ. Sci. Health Part A 2020, 55, 726–729. [Google Scholar] [CrossRef]
  59. Dimsdale, J.E. Psychological stress and cardiovascular disease. J. Am. Coll. Cardiol. 2008, 51, 1237–1246. [Google Scholar] [CrossRef] [Green Version]
  60. Steptoe, A.; Kivimäki, M. Stress and cardiovascular disease: An update on current knowledge. Annu. Rev. Public Health 2013, 34, 337–354. [Google Scholar] [CrossRef]
  61. Wild, C.P. Complementing the genome with an “exposome”: The outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Prev. Biomark. 2005, 14, 1847–1850. [Google Scholar] [CrossRef] [Green Version]
  62. Rougé-Pont, F.; Deroche, V.; Moal, M.L.; Piazza, P.V. Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur. J. Neurosci. 1998, 10, 3903–3907. [Google Scholar] [CrossRef]
  63. Anderson, N.B.; Armstead, C.A. Toward understanding the association of socioeconomic status and health: A new challenge for the biopsychosocial approach. Psychosom. Med. 1995, 57, 213–225. [Google Scholar] [CrossRef]
  64. Juster, R.-P.; Lupien, S. A sex-and gender-based analysis of allostatic load and physical complaints. Gend. Med. 2012, 9, 511–523. [Google Scholar] [CrossRef]
  65. Mattei, J.; Demissie, S.; Falcon, L.M.; Ordovas, J.M.; Tucker, K. Allostatic load is associated with chronic conditions in the Boston Puerto Rican Health Study. Soc. Sci. Med. 2010, 70, 1988–1996. [Google Scholar] [CrossRef] [Green Version]
  66. Roy, S.; Edwards, M.A. Preventing another lead (Pb) in drinking water crisis: Lessons from the Washington DC and Flint MI contamination events. Curr. Opin. Environ. Sci. Health 2019, 7, 34–44. [Google Scholar] [CrossRef]
  67. Egendorf, S.P.; Cheng, Z.; Deeb, M.; Flores, V.; Paltseva, A.; Walsh, D.; Groffman, P.; Mielke, H.W. Constructed soils for mitigating lead (Pb) exposure and promoting urban community gardening: The New York City Clean Soil Bank pilot study. Landsc. Urban Plan. 2018, 175, 184–194. [Google Scholar] [CrossRef]
  68. Wade, A.M.; Richter, D.D.; Craft, C.B.; Bao, N.Y.; Heine, P.R.; Osteen, M.C.; Tan, K.G. Urban-Soil Pedogenesis Drives Contrasting Legacies of Lead from Paint and Gasoline in City Soil. Environ. Sci. Technol. 2021, 55, 7981–7989. [Google Scholar] [CrossRef]
  69. Mielke, H.W.; Zahran, S. The urban rise and fall of air lead (Pb) and the latent surge and retreat of societal violence. Environ. Int. 2012, 43, 48–55. [Google Scholar] [CrossRef]
  70. Obeng-Gyasi, E.; Weinstein, M.A.; Hauser, J.R.; Obeng, C.S. Teachers’ Strategies in Combating Diseases in Preschools’ Environments. Children 2018, 5, 117. [Google Scholar] [CrossRef] [Green Version]
  71. Smith, D.; Hernandez-Avila, M.; Téllez-Rojo, M.M.; Mercado, A.; Hu, H. The relationship between lead in plasma and whole blood in women. Environ. Health Perspect. 2002, 110, 263–268. [Google Scholar] [CrossRef]
  72. Obeng-Gyasi, E. Lead exposure and cardiovascular disease among young and middle-aged adults. Med. Sci. 2019, 7, 103. [Google Scholar] [CrossRef] [Green Version]
  73. Jorm, A.F.; Windsor, T.D.; Dear, K.; Anstey, K.J.; Christensen, H.; Rodgers, B. Age group differences in psychological distress: The role of psychosocial risk factors that vary with age. Psychol. Med. 2005, 35, 1253–1263. [Google Scholar] [CrossRef]
Table
Table 1. Means (stderr) and prevalence of analysis variables across BLL levels above and below the 50th percentile in US population.
Table 1. Means (stderr) and prevalence of analysis variables across BLL levels above and below the 50th percentile in US population.
BLL above 50th PercentileBLL below 50th Percentile
Allostatic Load 2.16 (0.022)2.10 (0.024)
GenderM: 61.7 (0.51)M:36.3 (0.51)
F: 38.33 (0.51)F: 63.7 (0.51)
BMI27.8 (0.081)29.5 (0.123)
Race/Ethnicity
A) WhiteA) 70.1%A) 72.2%
B) BlackB) 11.3%B) 10.3%
C) Mexican AmericanC) 8.5%C) 7.3%
D) Other HispanicD) 5.0%D) 5.4%
Alcohol0.06%(0.03)0.02% (0.01)
Smoking2.3% (0.20)1.23%( 0.16)
Table
Table 2. Association between AL and BLL.
Table 2. Association between AL and BLL.
Linear RegressionN = 4268Unadjusted AL betap-value* Adjusted AL betap-value
BLL dichotomized at 50%0.0657 (0.023) 0.0050.255 (0.043)0.0001
Logistic
Regression		N = 4268Unadjusted AL 3 ORp-value* Adjusted AL 3 ORp-value
BLL dichotomized at 50%1.11 (0.05)0.0151.52 (0.113)0.0001
N = 4268Unadjusted AL 4 ORp-value* Adjusted AL 4 ORp-value
BLL dichotomized at 50%1.16 (0.75)0.0291.73 (0.168)0.0001
* Adjusted for gender, BMI, smoking, alcohol consumption, country of birth, and income.
Table
Table 3. Cardiovascular mortality risk in adults exposed to Pb and Stress.
Table 3. Cardiovascular mortality risk in adults exposed to Pb and Stress.
Unadjusted HRp-Value* Adjusted HRp-Value
BLL2.94 (0.293)0.00012.35 (0.298)0.0001
AL0.984 (0.135)0.9081.078 (0.101)0.435
AL X BLL1.96 (0.323)0.00011.82 (0.370)0.014
* Adjusted for gender, BMI, alcohol consumption, smoking, country of birth.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Obeng-Gyasi, E.; Ferguson, A.C.; Stamatakis, K.A.; Province, M.A. Combined Effect of Lead Exposure and Allostatic Load on Cardiovascular Disease Mortality—A Preliminary Study. Int. J. Environ. Res. Public Health 2021, 18, 6879. https://doi.org/10.3390/ijerph18136879

AMA Style

Obeng-Gyasi E, Ferguson AC, Stamatakis KA, Province MA. Combined Effect of Lead Exposure and Allostatic Load on Cardiovascular Disease Mortality—A Preliminary Study. International Journal of Environmental Research and Public Health. 2021; 18(13):6879. https://doi.org/10.3390/ijerph18136879

Chicago/Turabian Style

Obeng-Gyasi, Emmanuel, Alesia C. Ferguson, Katherine A. Stamatakis, and Michael A. Province. 2021. "Combined Effect of Lead Exposure and Allostatic Load on Cardiovascular Disease Mortality—A Preliminary Study" International Journal of Environmental Research and Public Health 18, no. 13: 6879. https://doi.org/10.3390/ijerph18136879

APA Style

Obeng-Gyasi, E., Ferguson, A. C., Stamatakis, K. A., & Province, M. A. (2021). Combined Effect of Lead Exposure and Allostatic Load on Cardiovascular Disease Mortality—A Preliminary Study. International Journal of Environmental Research and Public Health, 18(13), 6879. https://doi.org/10.3390/ijerph18136879

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop